Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) — Strategic Asset Allocation Index
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) has a Strategic Asset Allocation Index of 19.3% as of June 2023. Strategic assets (PP&E of CN¥2.12 Billion plus long-term investments of CN¥-) total CN¥2.12 Billion, measured against net assets of CN¥10.98 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Jiangsu Yuyue Medical Equipment & Supply balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Jiangsu Yuyue Medical Equipment & Supply Co Ltd Strategic Asset Allocation Index (2005–2022)
This chart shows how Jiangsu Yuyue Medical Equipment & Supply Co Ltd's Strategic Asset Allocation Index has evolved across 18 annual periods from 2005 to 2022. As of June 2023, the index stands at 19.3%, representing strategic assets of CN¥2.12 Billion against net assets of CN¥10.98 Billion CNY. For live market cap and overall valuation, see 002223 market cap overview.
Annual Strategic Asset Allocation Index for Jiangsu Yuyue Medical Equipment & Supply Co Ltd (2005–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Jiangsu Yuyue Medical Equipment & Supply Co Ltd from 2005 to 2022, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Jiangsu Yuyue Medical Equipment & Supply for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 21.6% | CN¥2.17 Billion | CN¥2.17 Billion | CN¥- | CN¥10.07 Billion | ▼ -2.2 pp |
| 2021 | 23.8% | CN¥2.00 Billion | CN¥2.00 Billion | CN¥- | CN¥8.43 Billion | ▼ -1.1 pp |
| 2020 | 24.8% | CN¥1.86 Billion | CN¥1.86 Billion | CN¥- | CN¥7.49 Billion | ▼ -3.9 pp |
| 2019 | 28.7% | CN¥1.77 Billion | CN¥1.77 Billion | CN¥- | CN¥6.16 Billion | ▲ +2.4 pp |
| 2018 | 26.3% | CN¥1.46 Billion | CN¥1.16 Billion | CN¥291.65 Million | CN¥5.54 Billion | ▲ +6.6 pp |
| 2017 | 19.6% | CN¥1.09 Billion | CN¥881.86 Million | CN¥212.62 Million | CN¥5.57 Billion | ▲ +7.0 pp |
| 2016 | 12.6% | CN¥623.18 Million | CN¥515.10 Million | CN¥108.08 Million | CN¥4.94 Billion | ▼ -13.2 pp |
| 2015 | 25.8% | CN¥551.04 Million | CN¥463.26 Million | CN¥87.78 Million | CN¥2.13 Billion | ▲ +1.5 pp |
| 2014 | 24.4% | CN¥428.99 Million | CN¥428.99 Million | CN¥- | CN¥1.76 Billion | ▼ -7.6 pp |
| 2013 | 32.0% | CN¥485.30 Million | CN¥485.30 Million | CN¥- | CN¥1.52 Billion | ▲ +0.3 pp |
| 2012 | 31.7% | CN¥416.12 Million | CN¥416.12 Million | CN¥- | CN¥1.31 Billion | ▼ -3.5 pp |
| 2011 | 35.3% | CN¥390.64 Million | CN¥390.64 Million | CN¥- | CN¥1.11 Billion | ▼ -0.6 pp |
| 2010 | 35.9% | CN¥315.30 Million | CN¥315.30 Million | CN¥- | CN¥879.47 Million | ▼ -17.5 pp |
| 2009 | 53.3% | CN¥257.31 Million | CN¥257.31 Million | CN¥- | CN¥482.51 Million | ▲ +10.7 pp |
| 2008 | 42.6% | CN¥173.03 Million | CN¥173.03 Million | CN¥- | CN¥405.69 Million | ▼ -64.5 pp |
| 2007 | 107.2% | CN¥146.85 Million | CN¥146.85 Million | CN¥- | CN¥137.01 Million | ▲ +68.6 pp |
| 2006 | 38.6% | CN¥59.55 Million | CN¥59.55 Million | CN¥- | CN¥154.18 Million | ▲ +22.6 pp |
| 2005 | 16.1% | CN¥23.08 Million | CN¥23.08 Million | CN¥- | CN¥143.67 Million | — |